Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
Once a woman turns 40, experts advise that she at the very least think about starting a breast cancer screening program. According to a recent study, Black women need this advice above all others.
Read Full NewsAmong young women with BRCA1/2 mutations and breast cancer, bilateral mastectomy rates increased substantially from 2000 to 2020.
Children with IgA nephropathy who achieve sustained proteinuria remission have significantly better long-term kidney function over 5 years than those who do not.
Researchers conduct a study of about 4000 women with pathogenic variants in at least one of 13 breast cancer susceptibility genes to see their utilization of cancer risk-reducing procedures.
In patients who face difficulty seeing in low light, a once-nightly eye drop significantly improves night vision and reduces glare, halos, and starbursts, a phase 3 trial shows.
Adjunctive serial IV ketamine infusions significantly reduced depressive symptoms in TRBD, with no cases of mania, hypomania, or psychosis observed in the randomized trial.
A digital pillbox with medication reminders and adherence feedback improves viral suppression in young people with HIV over 6 months, a trial finds.
Various factors such as menstrual history, pain conditions, and immune disorders are distinctly tied to endometriosis lesion types — superficial lesions, ovarian cysts, and deep lesions.
1.
Combination therapy improves outcomes for advanced triple-negative breast cancer
2.
Testosterone recovery linked to overall survival in high-risk prostate cancer
3.
FDA Approves First Menin Inhibitor for Acute Leukemia
4.
NEJM: Pirtobrutinib is effective in CLL patients who have received prior BTK inhibitor therapy.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
The Ultimate Guide to Understanding Abiraterone and its Uses in Cancer Treatment
2.
Acrochordon: What It Is, Causes, And How To Manage This Skin Condition
3.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
4.
Regenerative Reprogramming of Dormant Cellular Niches Following Cancer Therapy
5.
Progressive Trends in Hematology and Patient Outcomes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
2.
Navigating the Complexities of Ph Negative ALL - Part XVI
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
Clinical Insights in Oncology
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge